The University of Chicago Medical Center (UCMC) — Chicago, Illinois

Public research footprint of The University of Chicago Medical Center (UCMC), compiled from the ClinicalTrials.gov public registry.

203

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Advanced Non-small Cell Lung Cancer, HER2 Mutation · Squamous Cell Carcinoma of Head and Neck · Carcinoma, Non-Small-Cell Lung · Idiopathic Inflammatory Myopathy

Recently updated registry entries

NCT07085104 — A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR… (Recruiting)
NCT06408935 — Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients (Active Not Recruiting)
NCT07276399 — A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at The University of Chicago Medical Center (UCMC)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.